NRX Pharmaceuticals(NRXP) - 2025 Q4 - Earnings Call Transcript

NRx Pharmaceuticals (NasdaqCM:NRXP) Q4 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsJonathan Javitt - Founder, Chairman and CEOMichael Abrams - CFOPatrick R. Trucchio - Managing Director of Equity ResearchConference Call ParticipantsEdward Moon - AnalystThomas Shrader - Managing Director and Senior Biotechnology Equity Research AnalystOperatorMorning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Q4 2025 results conference call. At this time, all lines are in listen-only ...